Uricaemia as a surrogate endpoint in gout trials and the treat-to-target approach for gout management

被引：1
|
作者：
Bardin, Thomas [1 ,2 ]
Richette, Pascal [3 ,4 ]
机构：
[1] Univ Paris, INSERM, U1132, F-75010 Paris, France
[2] Inst Mutualiste Montsouris, Dept Med, Paris, France
[3] Hop Lariboisiere, APHP Paris Nord, Dept Rheumatol, Paris, France
[4] Univ Paris, INSERM, U1132, Paris, France
来源：
LANCET RHEUMATOLOGY | 2022年 / 4卷 / 01期
关键词：
D O I：
10.1016/S2665-9913(21)00358-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：E7 / E8
页数：2
相关论文
共 50 条
  • [31] Determinants of Achieving Serum Urate Goal with Treat-to-Target Urate-Lowering Therapy in Gout
    不详
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (04)
  • [32] Determinants of Achieving Serum Urate Goal with Treat-to-Target Urate-Lowering Therapy in Gout
    Helget, Lindsay N.
    O'Dell, James R.
    Newcomb, Jeff A.
    Androsenko, Maria
    Brophy, Mary T.
    Davis-Karim, Anne
    England, Bryant R.
    Ferguson, Ryan
    Pillinger, Michael H.
    Neogi, Tuhina
    Palevsky, Paul M.
    Wu, Hongsheng
    Kramer, Bridget
    Mikuls, Ted R.
    LANCET RHEUMATOLOGY, 2023, 5 (12): : e706 - e706
  • [33] Treat-to-Target urate-lowering therapy in primary gout patients: A real-world retrospective study at a dedicated gout clinic in China
    Bai, Xue-Shan
    Wang, Ming
    Zhao, Xiao-Dong
    Cui, Ling-Ling
    He, Yu-Wei
    Wang, Can
    Li, Xin-De
    Qu, Xiao-Jie
    Sun, Ming-Shu
    Li, Chang-Gui
    TECHNOLOGY AND HEALTH CARE, 2021, 29 (01) : 121 - 131
  • [34] Correspondence on 'Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study'
    Hung, Po-Cheng
    Lin, Da-Hung
    Ker, Amy
    Yang, Chieh-Chun
    Chien, Hung-Wan
    Wei, James Cheng-Chung
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (11) : E235
  • [35] TREAT-TO-TARGET CONSENSUS MANAGEMENT APPROACH FOR PEDIATRIC OSTEOPOROSIS
    El Miedany, Y.
    Salah, W.
    Lofty, H.
    Mekawy, D.
    Elaroussy, N.
    Hassan, M.
    Mortada, M.
    Elderiny, G.
    Ismail, N.
    Farag, Y.
    Suliman, Y.
    Eissa, M.
    El Gaafary, M.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S563 - S564
  • [36] Treat-to-target approach in the management of inflammatory Bowel disease
    Paulina Nunez, F.
    Mahadevan, Uma
    Quera, Rodrigo
    Bay, Constanza
    Ibanez, Patricio
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2021, 44 (04): : 312 - 319
  • [37] Ultrasound Shows Rapid Reduction of Uric Load during Treat-to-Target Approach in Gout Patients: Results from a Longitudinal Study
    Hammer, Hilde B.
    Karoliussen, Lars Fritjof
    Terslev, Lene
    Haavardsholm, Espen A.
    Kvien, Tore
    Uhlig, Till
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [38] Ultrasound Demonstrates Rapid Reduction of Crystal Depositions During a Treat-to-target Approach in Gout Patients: Two-year Results from a Longitudinal, Observational Study (NOR-GOUT)
    Hammer, Hilde
    Karoliussen, Lars
    Terslev, Lene
    Haavardsholm, Espen A.
    Kvien, Tore
    Uhlig, Till
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [39] TWO-YEAR REDUCTION OF URATE LOAD IN DUAL-ENERGY CT DURING A TREAT-TO-TARGET APPROACH IN GOUT PATIENTS: RESULTS FROM A LONGITUDINAL STUDY (NOR-GOUT)
    Uhlig, T.
    Eskild, T.
    Karoliussen, L. F.
    Kvien, T. K.
    Haavardsholm, E. A.
    Dalbeth, N.
    Hammer, H. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 281 - 282
  • [40] CAN DOCTORS TREAT GOUT WELL? INSIGHT ON GOUT MANAGEMENT IN REFERRAL CENTRES
    Jauffret, C.
    Ottaviani, S.
    Latourte, A.
    Ea, H. K.
    Graf, S.
    Liote, F.
    Bardin, T.
    Richette, P.
    Pascart, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 909 - 909
12345